ATLANTA (May 19, 2022) – The Society for Cardiovascular Angiography & Interventions (SCAI) today released official guidelines for the management of patent foramen ovale (PFO). A multidisciplinary ...

Sahajanand Medical Technologies (SMT) is using its Cocoon Occluder devices to treat congenital heart defects like atrial septal defect and patent foramen ovale. These minimally invasive devices ...

Researchers found closure of patent foramen ovale could result in reduced monthly migraine days. Treatment with patent foramen ovale (PFO) closure could reduce the frequency of headaches and monthly ...

Abbott announced that the FDA has approved its patent foramen ovale occlusion system for patients with a PFO and prior stroke at risk for recurrent ischemic stroke. According to a company press ...

Closure may be safe in patients older than 60 years who’ve had a presumed patent foramen ovale (PFO)-related stroke—a population excluded from most of the randomized trials in this space—but may also ...

Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and accounting for more than 4.18 million cases in children under five1.

The Nature Index 2024 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Atrial septal aneurysm means that there is a bulge in the interatrial septum. It may not present with symptoms. However, it can occur alongside other heart problems that cause symptoms such as ...